Global and United States Rapid Acting Insulins Market Report & Forecast 2023-2028

Report ID: 1873728 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rapid Acting Insulins Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Rapid Acting Insulins Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Rapid Acting Insulins Market Size for the Year 2017-2028
        1.2.2 Global Rapid Acting Insulins Market Size for the Year 2017-2028
    1.3 Rapid Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Rapid Acting Insulins in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Rapid Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Rapid Acting Insulins Market Dynamics
        1.4.1 Rapid Acting Insulins Industry Trends
        1.4.2 Rapid Acting Insulins Market Drivers
        1.4.3 Rapid Acting Insulins Market Challenges
        1.4.4 Rapid Acting Insulins Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Rapid Acting Insulins by Type
    2.1 Rapid Acting Insulins Market Segment by Type
        2.1.1 Lispro
        2.1.2 Aspart (NovoLog)
        2.1.3 Glulisine (Apidra)
    2.2 Global Rapid Acting Insulins Market Size by Type (2017, 2022 & 2028)
    2.3 Global Rapid Acting Insulins Market Size by Type (2017-2028)
    2.4 United States Rapid Acting Insulins Market Size by Type (2017, 2022 & 2028)
    2.5 United States Rapid Acting Insulins Market Size by Type (2017-2028)
3 Rapid Acting Insulins by Application
    3.1 Rapid Acting Insulins Market Segment by Application
        3.1.1 Type 1 Diabetes
        3.1.2 Type 2 Diabetes
    3.2 Global Rapid Acting Insulins Market Size by Application (2017, 2022 & 2028)
    3.3 Global Rapid Acting Insulins Market Size by Application (2017-2028)
    3.4 United States Rapid Acting Insulins Market Size by Application (2017, 2022 & 2028)
    3.5 United States Rapid Acting Insulins Market Size by Application (2017-2028)
4 Global Rapid Acting Insulins Competitor Landscape by Company
    4.1 Global Rapid Acting Insulins Market Size by Company
        4.1.1 Top Global Rapid Acting Insulins Companies Ranked by Revenue (2021)
        4.1.2 Global Rapid Acting Insulins Revenue by Player (2017-2022)
    4.2 Global Rapid Acting Insulins Concentration Ratio (CR)
        4.2.1 Rapid Acting Insulins Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Rapid Acting Insulins in 2021
        4.2.3 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Rapid Acting Insulins Headquarters, Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Rapid Acting Insulins Headquarters and Area Served
        4.3.2 Global Rapid Acting Insulins Companies Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Rapid Acting Insulins Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Rapid Acting Insulins Market Size by Company
        4.5.1 Top Rapid Acting Insulins Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Rapid Acting Insulins Revenue by Players (2020, 2021 & 2022)
5 Global Rapid Acting Insulins Market Size by Region
    5.1 Global Rapid Acting Insulins Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Rapid Acting Insulins Market Size by Region (2017-2028)
        5.2.1 Global Rapid Acting Insulins Market Size by Region: 2017-2022
        5.2.2 Global Rapid Acting Insulins Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Rapid Acting Insulins Market Size YoY Growth 2017-2028
        6.1.2 North America Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Rapid Acting Insulins Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Rapid Acting Insulins Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Rapid Acting Insulins Market Size YoY Growth 2017-2028
        6.3.2 Europe Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Rapid Acting Insulins Market Size YoY Growth 2017-2028
        6.4.2 Latin America Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Rapid Acting Insulins Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Details
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Rapid Acting Insulins Introduction
        7.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022)
        7.1.5 Eli Lilly Recent Development
    7.2 Novo Nordisk
        7.2.1 Novo Nordisk Company Details
        7.2.2 Novo Nordisk Business Overview
        7.2.3 Novo Nordisk Rapid Acting Insulins Introduction
        7.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022)
        7.2.5 Novo Nordisk Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Company Details
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Rapid Acting Insulins Introduction
        7.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2017-2022)
        7.3.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Rapid Acting Insulins Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Rapid Acting Insulins Market Trends
    Table 3. Rapid Acting Insulins Market Drivers
    Table 4. Rapid Acting Insulins Market Challenges
    Table 5. Rapid Acting Insulins Market Restraints
    Table 6. Global Rapid Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Rapid Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Rapid Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Rapid Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Rapid Acting Insulins Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Rapid Acting Insulins Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Rapid Acting Insulins Revenue Share by Player, 2017-2022
    Table 13. Global Rapid Acting Insulins Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rapid Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Acting Insulins as of 2021)
    Table 15. Top Players of Rapid Acting Insulins in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Rapid Acting Insulins Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Rapid Acting Insulins Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Rapid Acting Insulins Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Rapid Acting Insulins Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Rapid Acting Insulins Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Rapid Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Rapid Acting Insulins Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Rapid Acting Insulins Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eli Lilly Company Details
    Table 31. Eli Lilly Business Overview
    Table 32. Eli Lilly Rapid Acting Insulins Product
    Table 33. Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
    Table 34. Eli Lilly Recent Development
    Table 35. Novo Nordisk Company Details
    Table 36. Novo Nordisk Business Overview
    Table 37. Novo Nordisk Rapid Acting Insulins Product
    Table 38. Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
    Table 39. Novo Nordisk Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Rapid Acting Insulins Product
    Table 43. Sanofi Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Research Programs/Design for This Report
    Table 46. Key Data Information from Secondary Sources
    Table 47. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rapid Acting Insulins Product Picture
    Figure 2. Global Rapid Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Rapid Acting Insulins Market Size 2017-2028 (US$ Million)
    Figure 4. United States Rapid Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Rapid Acting Insulins Market Size 2017-2028 (US$ Million)
    Figure 6. United States Rapid Acting Insulins Market Share in Global 2017-2028
    Figure 7. Rapid Acting Insulins Report Years Considered
    Figure 8. Product Picture of Lispro
    Figure 9. Product Picture of Aspart (NovoLog)
    Figure 10. Product Picture of Glulisine (Apidra)
    Figure 11. Global Rapid Acting Insulins Market Share by Type in 2022 & 2028
    Figure 12. Global Rapid Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Rapid Acting Insulins Market Share by Type (2017-2028)
    Figure 14. United States Rapid Acting Insulins Market Share by Type in 2022 & 2028
    Figure 15. United States Rapid Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Rapid Acting Insulins Market Share by Type (2017-2028)
    Figure 17. Product Picture of Type 1 Diabetes
    Figure 18. Product Picture of Type 2 Diabetes
    Figure 19. Global Rapid Acting Insulins Market Share by Application in 2022 & 2028
    Figure 20. Global Rapid Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Rapid Acting Insulins Market Share by Application (2017-2028)
    Figure 22. United States Rapid Acting Insulins Market Share by Application in 2022 & 2028
    Figure 23. United States Rapid Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Rapid Acting Insulins Market Share by Application (2017-2028)
    Figure 25. North America Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
    Figure 54. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
    Figure 55. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novo Nordisk
Sanofi
Frequently Asked Questions
Rapid Acting Insulins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rapid Acting Insulins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rapid Acting Insulins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Long Acting Insulins

Long Acting Insulins market is segmented by region (country), players, by Type and by Application ... Read More

Premix Insulin

Premix Insulin market is segmented by region (country), players, by Type and by Application. Play ... Read More